Myriad Genetics
MYGN
#7134
Rank
S$0.66 B
Marketcap
S$7.14
Share price
1.44%
Change (1 day)
-59.12%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -S$0.54 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are S$0.82 Billion. In 2024 the company made an earning of -S$0.16 Billion, an increase over its 2023 earnings that were of -S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.54 Billion250.79%
2024 -S$0.16 Billion-53.49%
2023 -S$0.33 Billion88.72%
2022 -S$0.18 Billion172.08%
2021 -S$64.19 Million
2019 -S$33.43 Million-175.14%
2018 S$44.48 M-70.81%
2017 S$0.15 B22.22%
2016 S$0.12 B-38.8%
2015 S$0.20 B-6.12%
2014 S$0.21 B-41.07%
2013 S$0.36 B46.67%
2012 S$0.25 B15.84%
2011 S$0.21 B17.6%
2010 S$0.18 B-15.96%
2009 S$0.21 B
2007 -S$52.98 Million40.96%
2006 -S$37.58 Million
2003 -S$43.64 Million34.8%
2002 -S$32.38 Million89.21%
2001 -S$17.11 Million3.93%
2000 -S$16.47 Million21.76%
1999 -S$13.53 Million-25.61%
1998 -S$18.18 Million38.83%
1997 -S$13.1 Million-24.26%
1996 -S$17.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
S$10.34 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-S$1.24 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.86 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-S$44.45 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-S$1.08 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA